As of 19 Nov 2026, MedInTech has raised $25.4M across 1 verified round on record (amounts in other currencies converted to USD); latest: KRW 33.8 billion Series C led by Atinum Investment and KB Investment, announced 17 Nov 2026.
AI robotic endoscope developer
medintech.co.krLinkedInSouth KoreaHealthtechFounded 2020
2 sources · checked 1 time, last 4h ago
Source 2 gives the equivalent amount as $25.7 million; the more specific source 1 reports KRW 33.8 billion, which is used. Source 1 says the Series C may receive additional fundraising before closing, but reports KRW 33.8 billion as raised in this round.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series C | $25.4M $47.3M to date KRW 33.8 billion | 2026-11-17 | Atinum Investment, KB Investment | 1 person on X · 2 outlets. #116 in Trending |
2 sources · checked 1 time, last 4h ago [ VERIFIED · CORRECTED ] read against 2 sources
Source 2 gives the equivalent amount as $25.7 million; the more specific source 1 reports KRW 33.8 billion, which is used. Source 1 says the Series C may receive additional fundraising before closing, but reports KRW 33.8 billion as raised in this round. | ||||
1 person on 2 outlets
Found on X with Firecrawl search
MedInTech builds motorized, AI-assisted endoscopes and related imaging and lesion-detection software for doctors and hospitals.
MedInTech addresses the long-standing burden of manually pulling wires and turning wheels during endoscopy in a market dominated by Japanese manufacturers: its motorized scopes are about half the weight of conventional models, while its AI can detect abnormalities and assist with steering and lesion tracking; trials reported non-inferior maneuverability and lower clinician fatigue. Its Series C raised 33.8 billion won and brought cumulative funding to about 62.2 billion won, giving the company capital to expand its AI robotic-endoscope lineup and move into treatment and surgical robots after supplying Korean hospitals and making initial sales in Thailand, the Philippines, and Mongolia.
Checked against 10 sources today
| EARLIER ROUNDS FROM COMPANY RESEARCH · DEVELOPING | ||||
| Series A | ₩8 billion | 2022-02-14 | not stated | |
Also named as backers in company research: FuturePlay, Industrial Bank of Korea, Hana Ventures, Samchully Investment (SCL Investment), Gyeonggi Center for Creative Economy and Innovation, 2020 Preliminary Startup Package, MFDS Next Generation Medical Device 100 project, Startup Growth Technology Development Program, K-Global program, IP Narae Program, KERI Technology Commercialization Support Program, Pan-Ministerial Full-Cycle Medical Device R&D Program, Pan-Ministerial Advanced Medical Device R&D Program